![]() |
Gabi Edgerton B.S., Cornell University email: gbloom at uchicago dot edu Advisor: Dottie Hanck |
| Neuronal voltage-gated ion
channels allow the nervous system to
precisely modulate its excitability according to recent events and
changes in the local environment. Individual channels open and close in
response to fluctuations in membrane potential. Activation, the process
by which channels transition from a closed, non-conducting state to an
open conducting state, is mediated by conformational changes in the
four voltage sensors of these channels. Previous studies have shown
that differences in activation gating properties can be traced to
differences in the timing and coordination of voltage sensor movements.
Therefore, understanding how the voltage sensors move and coordinate
with one another during activation in different types of channels is
crucial in designing diagnostic, prophylactic, and therapeutic tools
that target specific channels. In voltage-gated sodium (Na) channels voltage sensor movements occur with different timecourses and likely exhibit differences in coupling. ProTxIl, a recently discovered tarantula peptide toxin, modifies activation in voltage-gated sodium (Na) channels. I plan to use this toxin to probe voltage sensor movements within individual domains of the channel during activation gating. Whole cell, single channel, and gating current analyses will help determine the mechanistic basis of the multiple effects of ProTxIl. Fluorescent labeling techniques combined with targeted mutagenesis will be used to systematically explore the site(s) of toxin interaction with each of the channel's voltage sensor regions. Disruptions in the effect of ProTxIl on gating in these mutants will reveal the domain-specific role of toxin interactions and voltage sensor movements in channel activation. Disruptions in Na channel gating are the cause of many severe neuropathies including epilepsy, sleep disorders, and neurogenic pain. Understanding the way these channels work is the necessary first step towards developing prophylactic and therapeutic tools for the prevention and treatment of these conditions. |
|
Committee on Neurobiology | University of Chicago |
| 04/04/08 |